HbA1c in the diagnosis of diabetes and abnormal glucose tolerance in patients with Graves' hyperthyroidism

Diabetes Research and Clinical Practice

Volumn 101, Issue 1, 2013, Pages 28-34

  Yang, Liyong ^a   Shen, Ximei ^a   Yan, Sunjie ^a   Yuan, Xin ^a   Lu, Juanjuan ^a   Wei, Wenfeng ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Diagnosis; General cardiovascular disease; Graves; HbA1c

Indexed keywords

HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EUTHYROIDISM; FEMALE; GLUCOSE METABOLISM; GRAVES DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHINA; COMPARATIVE STUDY; COMPLICATION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERTHYROIDISM; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDIABETIC STATE; PROGNOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHINA; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GRAVES DISEASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; PREDIABETIC STATE; PROGNOSIS; YOUNG ADULT;

EID: 84879604408     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.04.008     Document Type: Article

References (30)

1. Ginter E., Simko V. Diabetes type 2 pandemic in 21st century. Bratisl Lek Listy 2010, 111:134-137.
2. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
3. Khuwaja A.K., Khowaja L.A., Cosgrove P. The economic costs of diabetes in developing countries: some concerns and recommendations. Diabetologia 2010, 53:389-390.
4. Dall T.M., Zhang Y., Chen Y.J., Quick W.W., Yang W.G., Fogli J. The economic burden of diabetes. Health Aff (Millwood) 2010, 29:297-303.
5. American Diabetes Association Standards of medical care in diabetes-2010. Diabetes Care 2010, 33:S11-S61.
6. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33:S62-S69.
7. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34(Suppl. 1):S62-S69.
8. Report of a World Health Organization Consultation Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 2011, 93:299-309.
9. Tapp R.J., Tikellis G., Wong T.Y., Harper C.A., Zimmet P.Z., Shaw J.E., et al. Longitudinal association of glucose metabolism with retinopathy: results from the Australian diabetes obesity and lifestyle (AusDiab) study. Diabetes Care 2008, 31:1349-1354.
10. Manley S. Haemoglobin A1c - a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 2003, 41:1182-1190.
11. Sabanayagam C., Liew G., Tai E.S., Shankar A., Lim S.C., Subramaniam T., et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?. Diabetologia 2009, 52:1279-1289.
12. Abdul-Ghani M.A., Abdul-Ghani T., Müller G., Bergmann A., Fischer S., Bornstein S., et al. Role of glycated hemoglobin in the prediction of future risk of T2DM. J Clin Endocrinol Metab 2011, 96:2596-2600.
13. Kumaravel B., Bachmann M.O., Murray N., Dhatariya K., Fenech M., John W.G., et al. Use of haemoglobin A1c to detect impaired fasting glucose or type 2 diabetes in a United Kingdom community based population. Diabetes Res Clin Pract 2012, 96:211-216.
14. Sinha N., Mishra T.K., Singh T., Gupta N. Effect of iron deficiency anemia on hemoglobin A1c levels. Ann Lab Med 2012, 32:17-22.
15. Herman W.H., Cohen R.M. Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. J Clin Endocrinol Metab 2012, 97:1067-1072.
16. Hardikar P.S., Joshi S.M., Bhat D.S., Raut D.A., Katre P.A., Lubree H.G., et al. Spuriously high prevalence of prediabetes diagnosed by HbA1c in young Indians partly explained by hematological factors and iron deficiency anemia. Diabetes Care 2012, 35:797-802.
17. Hage C., Lundman P., Rydén L., Mellbin L. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes. Eur J Prev Cardiol 2012, 28. [Published online before print] Available from:. http://cpr.sagepub.com/content/early/2012/03/27/2047487312444371.
18. Cohen R.M., Haggerty S., Herman W.H. HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction?. J Clin Endocrinol Metab 2010, 95:5203-5206.
19. Doar J.W., Stamp T.C., Wynn V., Audhya T.K. Effects of oral and intravenous glucose loading in thyrotoxicosis. Studies of plasma glucose, free fatty acid, plasma insulin and blood pyruvate levels. Diabetes 1969, 18:633-639.
20. Kreines K., Jett M., Knowles H.C. Observations in hyperthyroidism of abnormal glucose tolerance and other traits related to diabetes mellitus. Diabetes 1965, 14:740-744.
21. Bahn Chair R.S., Burch H.B., Cooper D.S., Garber J.R., Greenlee M.C., Klein I., et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011, 21:593-646.
22. Gabir M.M., Hanson R.L., Dabelea D., Imperatore G., Roumain J., Bennett P.H., et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000, 23:1108-1112.
23. D'Agostino R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., et al. General cardiovascular risk profile for use in primary care: the framingham heart study. Circulation 2008, 117:743-753.
24. Paul D.T., Mollah F.H., Alam M.K., Fariduddin M., Azad K., Arslan M.I. Glycemic status in hyperthyroid subjects. Mymensingh Med J 2004, 13:71-75.
25. Roubsanthisuk W., Watanakejorn P., Tunlakit M., Sriussadaporn S. Hyperthyroidism induces glucose intolerance by lowering both insulin secretion and peripheral insulin sensitivity. J Med Assoc Thai 2006, 89:S133-S140.
26. Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362:1090-1101.
27. Widya R.L., van der Meer R.W., Smit J.W., Rijzewijk L.J., Diamant M., Bax J.J., et al. Right ventricular involvement in diabetic cardiomyopathy. Diabetes Care 2013, 36:457-462.
28. Fadini G.P., Albiero M., Vigili de Kreutzenberg S., Boscaro E., Cappellari R., Marescotti M., et al. Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care 2013, 36:943-949.
29. Riddle M.C., Karl D.M. Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trials. Diabetes Care 2012, 35:2100-2107.
30. Boonman-de Winter L.J., Rutten F.H., Cramer M.J., Landman M.J., Liem A.H., Rutten G.E., et al. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia 2012, 55:2154-2162.